Biofrontera AG products
-
Ameluz®
-
Generic: aminolevulinic acid hydrochloride topical gel, 10%
-
Indication: photodynamic therapy (PDT) for actinic keratoses of the face and scalp
-
Dose / Usage: apply ~1 mm layer (max 6 g per session, 60 cm² area), occlude 3 hours, then illuminate with red light (~37 J/cm²); retreat after 3 months if needed
-
-
Belixos® (Dermocosmetic line)
-
Generic: medical-grade skincare formulations
-
Indication: soothing, regenerating, and protecting inflamed, itchy, or photodamaged skin
-
Dose / Usage: apply topically as directed; varies by product (cosmetic use, not prescription drug)
-
-
BF-RhodoLED® / RhodoLED XL
-
Generic: red-light medical device (PDT lamp)
-
Indication: illumination device used in conjunction with Ameluz® for actinic keratosis treatment
-
Usage: delivers ~37 J/cm² red light over ~10 minutes; proper positioning and eye protection required
-
-
Xepi®
-
Generic: ozenoxacin cream, 1%
-
Indication: topical treatment of impetigo in adults and children ≥ 2 months
-
Dose / Usage: thin layer to affected area twice daily for 5 days; maximum area 100 cm² (≤ 2% body surface in children < 12 years)
-
No comments:
Post a Comment